Improving the Management of Patients on Oral Regimens

Conference Correspondent  - Conference Correspondent, ASH
Beth Faiman, PhD, APRN-BC, AOCN
Editor in Chief

Beth Faiman elaborates on her idea wish list of resources and tools that would help her to better manage patients on oral oncolytics.

I often think of what my wish list would be for in a perfect world, how I would manage patients on in all oral regimen. If I could have somebody that could create calendars for may patients.

We have lots of tools that auto‑populate. But with these complex regimens, it's a challenge to get the dates right. If they miss a dose, how does that address? If I could have somebody to create a calendar or tool to help manage, that would be great.

The pharmaceutical companies and the pharmacies have staff, as I mentioned before, that help remind me to refill. Because remember these drugs are dosed, most of them at a monthly basis. At the end of each month, many of the drugs have to be refilled.

If there is a delay in dispensing on my end and a delay in dispensing on the pharmacy end, then that could put the patients off schedule. Keeping those resources available, those reminders available help me to do my job and help the patient get what they need.

Related Items
No Link between Long-Term Eltrombopag Treatment and Incidence of Cataracts in Adult Patients with Chronic ITP During EXTEND
Conference Correspondent  published on December 27, 2017 in ASH
Eltrombopag Treatment Improved Platelet Counts in Patients with Persistent or Chronic ITP
Conference Correspondent  published on December 27, 2017 in ASH
Fostamatinib-Treated Patients with Persistent/Chronic ITP Maintained Long-Term Responses
Conference Correspondent  published on December 27, 2017 in ASH
Avatrombopag Superior to Placebo for the Treatment of Chronic ITP
Conference Correspondent  published on December 27, 2017 in ASH
Subcutaneous Romiplostim Increased Platelet Response in Children with ITP
Conference Correspondent  published on December 27, 2017 in ASH
Centers for Disease Control and Prevention Guidelines on Opioid Use for Cancer Pain
Chase Doyle
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in Conference Correspondent, HOPA
Maintenance Chemotherapy After Hematopoietic Stem-Cell Transplantation
Chase Doyle
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in Conference Correspondent, HOPA
Graft-versus-Host Disease: Breakthroughs on the Horizon
Chase Doyle
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in Conference Correspondent, HOPA
Basket Clinical Trials: A New Era in Cancer Treatment
Chase Doyle
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in Conference Correspondent, HOPA
Burnout Rates High for Pharmacists in Hematopoietic Stem-Cell Transplantation
Chase Doyle
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in Conference Correspondent, HOPA
Last modified: April 27, 2020